These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6524403)

  • 1. [Biopharmaceutical evaluation of hydrocortisone acetate ointment applied to the skin].
    Umer S
    Acta Pol Pharm; 1984; 41(3):375-80. PubMed ID: 6524403
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adrenal cortex hormone preparations. VIII. Absorption of hydrocortisone acetate from ointments by rabbit skin].
    Nerlo H; Umer S
    Acta Pol Pharm; 1983; 40(2):207-10. PubMed ID: 6659999
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of ointment bases on the absorption of hydrocortisone acetate from ointments].
    Umer S
    Ann Univ Mariae Curie Sklodowska Med; 1982; 37():233-7. PubMed ID: 6927071
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioavailability of hydrocortisone acetate from ophthalmic ointments.
    Umer S
    Acta Pol Pharm; 1994; 51(1):39-43. PubMed ID: 7976432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biopharmaceutical evaluation of the effect of an ointment base composition on the biological availability of hydrocortisone acetate in the ointment].
    Umer S
    Acta Pol Pharm; 1985; 42(2):172-6. PubMed ID: 4083054
    [No Abstract]   [Full Text] [Related]  

  • 6. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Absorption of af 2071 (hydrocortisone-bendazac ester) after topical application compared with oral administration].
    Catanese B; Barillari G; Rossi V
    Boll Chim Farm; 1978 Jun; 117(6):368-74. PubMed ID: 743382
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of the degree of dispersion and of the type of ointment base on the skin absorption of hydrocortisone and prednisolone ointments].
    Skripkin IuK; Dobrotvorskiĭ AE; Demidova NM; Aliushin MT
    Vestn Dermatol Venerol; 1974 May; 48(5):19-21. PubMed ID: 4839253
    [No Abstract]   [Full Text] [Related]  

  • 10. [Liberation of hydrocortisone acetate from different commercial formulations].
    Neubert RH; Pötzsch A
    Pharmazie; 2004 Jun; 59(6):472-4. PubMed ID: 15248463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous pharmacokinetics: 10 steps to percutaneous absorption.
    Wester RC; Maibach HI
    Drug Metab Rev; 1983; 14(2):169-205. PubMed ID: 6341024
    [No Abstract]   [Full Text] [Related]  

  • 12. [Penetration of various labelled steroids into human skin].
    Zesch A; Schaefer H
    Arzneimittelforschung; 1973 Mar; 23(3):415-9. PubMed ID: 4740126
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental study of a gentamycin ointment].
    Kagan EZ; Vasil'ev VK; Bykova MA; Berezina EK
    Antibiotiki; 1978 Mar; 23(3):257-9. PubMed ID: 637532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of various marine lipids on transdermal drug delivery--in vitro evaluation.
    Loftsson T; Gunnarsdóttir T; Magnúsdóttir LM; Frioriksdóttir H; Guomundsdóttir TK; Olafsson JH; Haraldsson GG; Guomundsson G; Hjaltason B
    Boll Chim Farm; 1997 Nov; 136(10):640-5. PubMed ID: 9528172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transport mechanism and influencing factors on the ointment-skin and drug-ointment systems].
    Horsch W
    Pharmazie; 1984 Sep; 39(9):598-605. PubMed ID: 6504992
    [No Abstract]   [Full Text] [Related]  

  • 17. Penetration of hydrocortisone into excised human skin under the influence of cyclodextrins.
    Preiss A; Mehnert W; Frömming KH
    Pharmazie; 1995 Feb; 50(2):121-6. PubMed ID: 7700965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidermal reaction against hydrocortisone in different ointment bases (author's transl)].
    Wohlrab W; Zaumseil RP
    Dermatol Monatsschr; 1982 Apr; 168(4):236-42. PubMed ID: 7106335
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of biologic availability of active principles contained in galenic forms for cutaneous administration].
    Aiache JM; Aiache S; Guilpain G; Paire M
    Boll Chim Farm; 1977 Feb; 116(2):63-80. PubMed ID: 861080
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Topical availability of hydrocortisone from different ointment bases.
    Ritschel WA; Kitzmiller KW; Serracino-Inglott A
    Rev Can Biol; 1973; 32():Suppl:91-7. PubMed ID: 4777607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.